Interferon-α2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study

Background: Currently, there are no drugs that have been proven to be effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Because of its broad antiviral activity, interferon (IFN) should be evaluated as a potential therapeutic agent for treatment of coronavirus disease 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Shao-rui, Yan, Ren, Zhang, Shan-yan, Lian, Jiang-shan, Cai, Huan, Zhang, Xiao-li, Zheng, Lin, Jia, Hong-yu, Hu, Jian-hua, Yu, Guo-dong, Gu, Jue-qing, Ye, Chan-yuan, Jin, Ci-liang, Lu, Ying-feng, Xin, Jiao-jiao, Sheng, Ji-fang, Yang, Yi-da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Zhejiang University Press 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423845/
https://www.ncbi.nlm.nih.gov/pubmed/32748578
http://dx.doi.org/10.1631/jzus.B2000211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423845/
https://www.ncbi.nlm.nih.gov/pubmed/32748578
http://dx.doi.org/10.1631/jzus.B2000211

Ejemplares similares